Manzo Pharmaceuticals Statistics

Total Valuation

MNZO has a market cap or net worth of 1,100.

Market Cap	1,100
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

MNZO has 1.10 billion shares outstanding.

Current Share Class	1.10B
Shares Outstanding	1.10B
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1,375.67%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 0.00.

PE Ratio	0.00
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-0.00
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.20

Current Ratio	0.20
Quick Ratio	0.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	-7.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	36.85%
Revenue Per Employee	n/a
Profits Per Employee	646,223
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-109.46
52-Week Price Change	n/a
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	41.42
Average Volume (20 Days)	98,822

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.04

Income Statement

Revenue	n/a
Gross Profit	-517,227
Operating Income	-4.33M
Pretax Income	7.75M
Net Income	7.75M
EBITDA	-4.24M
EBIT	-4.33M
Earnings Per Share (EPS)	1.91

Full Income Statement

Balance Sheet

The company has 6,905 in cash and 5.12 million in debt, giving a net cash position of -5.11 million or -0.00 per share.

Cash & Cash Equivalents	6,905
Total Debt	5.12M
Net Cash	-5.11M
Net Cash Per Share	-0.00
Equity (Book Value)	-11.74M
Book Value Per Share	-2.24
Working Capital	-12.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.17 million and capital expenditures -531,363, giving a free cash flow of -9.71 million.

Operating Cash Flow	-9.17M
Capital Expenditures	-531,363
Free Cash Flow	-9.71M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNZO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.26%
Shareholder Yield	n/a
Earnings Yield	704,970.73%
FCF Yield	-882,303.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 17, 2014. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 17, 2014
Split Type	Reverse
Split Ratio	0.1

Scores

MNZO has an Altman Z-Score of -15.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.07
Piotroski F-Score	2